FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313329427> ?p ?o ?g. }

• W4313329427 endingPage "4062" @default.
• W4313329427 startingPage "4047" @default.
• W4313329427 abstract "Background: We hypothesized that superlative dual cytotoxicity-antiinflammtion bioefficacies of 9 selected lipophilic statins correlate to their chelation effect of 3,5-dihydroxyheptanoic acid. Methodology: Lipophilic-acid chelating statins have been screened for in vitro duality of proliferation inhibition and NO-radical scavenging capacities. Results: Their spectrum of selectivity indices for safety in PDL fibroblasts -based 72h incubations was reported. Surprisingly despite its lack on macrophages LPS-triggered inflammation over 5-200 µM and unlike the 8 statins; cerivastatin had growth inhibition IC50 values of 40nM (SW620), 110nM (HT29), 2.9 µM (HCT116), 6µM (SW480), and most notably 38µM (<50 µM, in Caco2). Exclusively cerivastatin exerted antitumorigenesis IC50 values <50 µM in all T47D, MCF7 and PANC1 72h cultures. In statins with greater antiinflammation affinity than indomethacin’s; lovastatin had cytotoxicity IC50 values <20 µM in SW620<HT29<ACT116100 µM in Caco2. Atorvastatin was found of viability reduction IC50 value <20 µM in HCT11650µM in T47D, MCF7 and PANC1. Rosuvastatin had antineoplastic IC50 values (<50 µM) in SW620<SW48050 µM in remaining colorectal, breast and pancreatic cancer cell lines. In statins with appreciable antiinflammation but reasonably lower affinity than indomethacin’s and cytotoxicity IC50 values >50µM in T47D, MCF7 and PANC1; pravastatin had viability reduction IC50 values <50µM in HT2950 µM were for statins in remaining colorectal cancer cell lines, breast cancer and pancreatic cancer cell lines.Conclusion: Among the rest, cerivastatin warrants further novel scaffold development to maximize efficacy and optimal molecular action mechanisms of chemotherapy/prevention." @default.
• W4313329427 created "2023-01-06" @default.
• W4313329427 creator A5020637836 @default.
• W4313329427 creator A5022719747 @default.
• W4313329427 creator A5023712780 @default.
• W4313329427 creator A5061396055 @default.
• W4313329427 creator A5063446792 @default.
• W4313329427 creator A5081993460 @default.
• W4313329427 creator A5086977872 @default.
• W4313329427 date "2022-12-01" @default.
• W4313329427 modified "2023-10-18" @default.
• W4313329427 title "Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds" @default.
• W4313329427 cites W1494133954 @default.
• W4313329427 cites W1572968453 @default.
• W4313329427 cites W1982811605 @default.
• W4313329427 cites W1983746805 @default.
• W4313329427 cites W1987730034 @default.
• W4313329427 cites W1990766453 @default.
• W4313329427 cites W1992540727 @default.
• W4313329427 cites W2010183849 @default.
• W4313329427 cites W2045480559 @default.
• W4313329427 cites W2092316845 @default.
• W4313329427 cites W2095877288 @default.
• W4313329427 cites W2097918221 @default.
• W4313329427 cites W2107841008 @default.
• W4313329427 cites W2123490784 @default.
• W4313329427 cites W2126372860 @default.
• W4313329427 cites W2126564019 @default.
• W4313329427 cites W2134355296 @default.
• W4313329427 cites W2159509177 @default.
• W4313329427 cites W2163014518 @default.
• W4313329427 cites W2252733636 @default.
• W4313329427 cites W2409215018 @default.
• W4313329427 cites W2593149695 @default.
• W4313329427 cites W2781762043 @default.
• W4313329427 cites W2783204748 @default.
• W4313329427 cites W2790564892 @default.
• W4313329427 cites W2903244520 @default.
• W4313329427 cites W2911188335 @default.
• W4313329427 cites W2925384056 @default.
• W4313329427 cites W2932081683 @default.
• W4313329427 cites W2999333081 @default.
• W4313329427 cites W3002110579 @default.
• W4313329427 cites W3086286620 @default.
• W4313329427 cites W3177413739 @default.
• W4313329427 cites W4280496343 @default.
• W4313329427 cites W4281907650 @default.
• W4313329427 cites W4288388823 @default.
• W4313329427 doi "https://doi.org/10.31557/apjcp.2022.23.12.4047" @default.
• W4313329427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36579985" @default.
• W4313329427 hasPublicationYear "2022" @default.
• W4313329427 type Work @default.
• W4313329427 citedByCount "3" @default.
• W4313329427 countsByYear W43133294272023 @default.
• W4313329427 crossrefType "journal-article" @default.
• W4313329427 hasAuthorship W4313329427A5020637836 @default.
• W4313329427 hasAuthorship W4313329427A5022719747 @default.
• W4313329427 hasAuthorship W4313329427A5023712780 @default.
• W4313329427 hasAuthorship W4313329427A5061396055 @default.
• W4313329427 hasAuthorship W4313329427A5063446792 @default.
• W4313329427 hasAuthorship W4313329427A5081993460 @default.
• W4313329427 hasAuthorship W4313329427A5086977872 @default.
• W4313329427 hasBestOaLocation W43133294271 @default.
• W4313329427 hasConcept C109316439 @default.
• W4313329427 hasConcept C185592680 @default.
• W4313329427 hasConcept C190283241 @default.
• W4313329427 hasConcept C202751555 @default.
• W4313329427 hasConcept C2776839432 @default.
• W4313329427 hasConcept C2777752497 @default.
• W4313329427 hasConcept C2778163477 @default.
• W4313329427 hasConcept C2779415389 @default.
• W4313329427 hasConcept C2779519902 @default.
• W4313329427 hasConcept C2780499067 @default.
• W4313329427 hasConcept C53227056 @default.
• W4313329427 hasConcept C55493867 @default.
• W4313329427 hasConcept C71924100 @default.
• W4313329427 hasConcept C98274493 @default.
• W4313329427 hasConceptScore W4313329427C109316439 @default.
• W4313329427 hasConceptScore W4313329427C185592680 @default.
• W4313329427 hasConceptScore W4313329427C190283241 @default.
• W4313329427 hasConceptScore W4313329427C202751555 @default.
• W4313329427 hasConceptScore W4313329427C2776839432 @default.
• W4313329427 hasConceptScore W4313329427C2777752497 @default.
• W4313329427 hasConceptScore W4313329427C2778163477 @default.
• W4313329427 hasConceptScore W4313329427C2779415389 @default.
• W4313329427 hasConceptScore W4313329427C2779519902 @default.
• W4313329427 hasConceptScore W4313329427C2780499067 @default.
• W4313329427 hasConceptScore W4313329427C53227056 @default.
• W4313329427 hasConceptScore W4313329427C55493867 @default.
• W4313329427 hasConceptScore W4313329427C71924100 @default.
• W4313329427 hasConceptScore W4313329427C98274493 @default.
• W4313329427 hasIssue "12" @default.
• W4313329427 hasLocation W43133294271 @default.
• W4313329427 hasLocation W43133294272 @default.
• W4313329427 hasLocation W43133294273 @default.
• W4313329427 hasOpenAccess W4313329427 @default.
• W4313329427 hasPrimaryLocation W43133294271 @default.
• W4313329427 hasRelatedWork W14027407 @default.

• next